Oxford Global Conferences are proud to announce the 2nd Annual Genome Editing Congress, taking place on 10-11 November 2016 at the Novotel London West in London, UK. This highly anticipated event provides a unique opportunity for over 450 senior level experts to engage in scientific discussions about the current research results and latest advancements that help the industry going forward.
The genome editing market represents a rapidly evolving area of pharmaceutical research since the discovery of the CRISPR/Cas systems that have revolutionised biological research. Significant advancements have been made in the fields of improving genome editing tools & technologies, gene delivery systems and utilising genome editing for therapeutic applications. Genomics research is experiencing an increased funding and thanks to the technological advancements the genome editing market is expected to grow rapidly. Experts have also highlighted that the global market for genome editing is expected to reach over $2.0 billion by 2020.
On day one our esteemed speakers will focus on topic areas covering genome editing techniques. Presentations will focus on the latest developments and novel methods for genome editing and engineering as well as advancements in gene editing systems. Genome editing using CRISPR, TALEN & ZFN systems and utilising genome editing in drug discovery and development will also be covered.
On day two delegates will have the unique chance to hear presentations on the therapeutic applications of genome editing. Our highly distinguished speakers will deliver case studies from cardiovascular diseases, diabetes, genetic disorders and gene therapy. Key opinion leaders will also address updates in novel genome engineering methods and improving genome targeting precision.